CTT Pharma's CEO will issue a Letter to Shareholders

(TheNewswire)

Tampa, Florida, United States – TheNewswire –November 20, 2025 - CTT Pharmaceutical Holdings, Inc.(OTCQB:CTTH) ispleased to announce that the CEO of CTT Pharma will issue a letter toshareholders on December 2, 2025. The letterwill outline several initiatives underway thatwill advance CTT’s strategic direction, including updates on our S-1 filing, which will allow CTT to become afull SEC reporting company.  Thus allowing CTT access to funding fromour equity line of credit, and help accelerate growth by monetizingthe company’s patents.  The letter will also include information about ongoing operational initiatives includingsteps toward preparing for manufacturing capabilities, as well asupdates on strategic partners who are aligned with CTT’scommercialization strategy.

Finally, shareholders will receive an update on therecent submission of our peer-reviewed scientific manuscript which brings to light the scientific foundation behindwhat we believe is a transformative technology in therapeutic drugdelivery.

CTT Pharma – 813-606-0060

Copyright (c) 2025 TheNewswire - All rights reserved.